Is COVID prematurely aging our immune systems?
Covid19-Sources
How multiple COVID-19 infections can harm the body
Association of the Fourth BNT162b Vaccine With SARS-CoV-2 Infection
GNB3 TT: Das Gen, das vor schweren Corona-Verläufen schützen kann | MDR.DE
Ambulante Akut- und Notfälle in Deutschland
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland
Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP
Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort study
The Efficacy of Facemasks in the Prevention of COVID-19: A Systematic Review
Britain’s not working
Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves - PubMed
Update Alert 8: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings | Annals of Internal Medicine
Vitamin D for COVID-19: real-time meta analysis of 214 studies
Long COVID could be linked to the effects of SARS-CoV-2 on the vagus nerve
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness
Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study - PubMed
A randomized pilot study using calcitriol in hospitalized COVID-19 patients
Vitamin D Deficiency and Outcome of COVID-19 Patients
Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality
Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
Johann Holzmann on Twitter
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients
Post–COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection
COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis